April 23, 2021
Salem-News.com Heath articles
Salem-News.com (Mar-25-2021 13:59)
7 Ways To Deal With A Complicated Custody BattleKim Hemphry Salem-News.com
You must head into court with a sound action plan.
(SALEM, Ore.) -
A child custody dispute can be one of the most traumatic things a parent can go through, particularly if you do not know what to expect.
Salem-News.com (Apr-19-2014 14:26)
Standing up to the FEDS About VaccinesSalem-News.com
CDC made a mockery of the Nuremberg code's directive that people must have "informed consent" when it refused to answer FOIA questions from a doctor whose son was autistic about the CDC's knowledge about mercury in vaccines and any discussions at the CDC about it.
(WASHINGTON DC) -
While alternative media is exposing so much of what the genocidal Cabal is doing, trying to start more wars, trying to grab land a la Agenda 21, rigging Wall Street, rigging the entire banking system and Comex, and since the Cabal has more in store, including (more) fake pandemics, it seems just the right time to expose their vaccines.
Salem-News.com (Apr-11-2014 11:17)
A Voice of Sanity About Childhood Vaccines from a Respected NephrologistGary G. Kohls MD for Salem-News.com
It is ironic, but telling, to note that a few years ago there was a $10,000 award offered to any physician who would be willing to swallow the contents of what they freely inject into their unsuspecting patients.
(DULUTH, MN) -
To my medical colleagues, BigPharma sceptics and others truly concerned with public health issues and the accelerating sickening of America:
Salem-News.com (Mar-31-2014 01:36)
Enrollment of the First Patient in the MF 1001 Glioblastoma Study at the Muenster University ClinicSalem-News.com
The new MF 1001 glioblastoma study is designed to validate the results generated with NanoTherm(R) therapy to date by means of a direct comparison with established radiotherapy in a large patient population.
(BERLIN ) -
MagForce AG (Frankfurt, Xetra: MF6), a leading medical technology company in the area of nanotechnology which focuses on oncology, today announced the enrollment of the first patient in the MF 1001 clinical study.